top of page
big title-23.png

我們致力於在癌症、免疫學、

公共衛生和個人化治療等不同領域提供治療、診斷和生產效益。

Quote

我們致力於推進微生物組研究並尋找針對不同健康狀況的創新解決方案,並在研究領域取得成功。

在 MagIC,我們致力於推動突破性發現,以實現個人化的醫療及改善治療效果。

MOZAIC

MOZAIC™

IBD-SMART™
Metagenomics Multiple Diseases Test
MetaGenie™
Long COVID Gut Microbiome Risk Test

IBD-SMART™

炎症性腸道疾病診斷的

大便微生物標誌物測試

微生態宏基因組學

多重疾病檢測

MetaGenie™

微生物菌群自閉症譜系障礙(ASD)診斷測試

長新冠型腸道

微生態風險檢測

Anchor 1

INVITATION FOR EXPRESSION OF INTEREST (EOI) 1. Fungome and FMT (Closed) [Invitation for Expression of Interest – Deadline: 19 May 2023] 2. ASD Multi-kingdom (Closed) [Invitation for Expression of Interest – Deadline: 21 Aug 2023] 3. CD Bacterial Markers (Closed) [Invitation for Expression of Interest – Deadline: 19 Feb 2024] 4. UC Bacterial Markers (Closed) [Invitation for Expression of Interest – Deadline: 19 Feb 2024] 5. MAFLD Formula (Closed) [Invitation for Expression of Interest – Deadline: 18 Mar 2024] 6. SIM05 Adult Eczema (Closed) [Invitation for Expression of Interest – Deadline: 28 Mar 2024] 7. SCM06 Mood (Closed) [Invitation for Expression of Interest – Deadline: 28 Ma 8. Synbiotics for ADHD [Licensing negotiation in progress] [Invitation for Expression of Interest- Deadline: 1 August 2026] We are inviting expressions of interest (EoI) for commercializing “Synbiotics for ADHD” technology. The innovation is developed by researchers of Microbiota I-Center (MagIC) (MagIC Reference: 26/MAG/022). The Technology This invention relates to the use of a synbiotic composition to improve attention-deficit/hyperactivity disorder (ADHD) symptoms through modulation of the gut microbiome. This invention provide an adjunctive strategy that complements conventional ADHD treatments by targeting microbiome-related mechanisms rather than solely neurotransmitter pathways. Commercialization The technology is now available for licensing on an exclusive basis. In order to fully realize the benefit of the technology, we expect substantial investment is necessary to enable further research and development. In addition to the financial commitment, the licensee is expected to have the appropriate expertise as well as plans in marketing and strategizing the end product to ensure successful transfer of the technology to the society. Previous or existing business involvement and experience in this area is a plus. This invitation of expression of interest is without prejudice. We also stress that this invitation is not a tender, and MagIC is not bound to accept any offer, or to accept the highest monetary offer, as there are additional considerations (such as the widest possible benefit to the community) that we, as a public institution, will need to take into consideration. For inquiries about licensing opportunity, contact: Ms Mandy Lee Microbiota I-Center (MagIC) contact@magic-inno.hk Lead inventor: Prof. NG Siew Chien

追蹤我們
  • website idea-0905-20
  • website idea-0905-19
  • website idea-0905-18
  • wechat

辦公室

沙田白石角香港科學園科技大道西17號17W,

10樓 1001至1002室及1015至1016室

Microbiota I-Center (MagIC)

© 2025 by InnoHK Microbiota I-Center (MagIC) Limited. All Rights Reserved. 

實驗室及動物實驗室

沙田白石角香港科學園科技大道西17號17W,

13樓 1301室及1307室

bottom of page